sulfamethoxypyridazine has been researched along with Congenital Infection, Toxoplasma gondii in 2 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MOHR, W | 1 |
| PIEKARSKI, G | 1 |
| Kocher, R | 1 |
| Haensch, G | 1 |
1 review available for sulfamethoxypyridazine and Congenital Infection, Toxoplasma gondii
| Article | Year |
|---|---|
[New viewpoints on the treatment of toxoplasmosis].
Topics: Age Factors; Child, Preschool; Demeclocycline; Female; Humans; Infant; Leucomycins; Pregnancy; Pyrim | 1973 |
1 other study available for sulfamethoxypyridazine and Congenital Infection, Toxoplasma gondii
| Article | Year |
|---|---|
[TOXOPLASMOSIS, A NOTIFIABLE INFECTIOUS DISEASE].
Topics: Communicable Diseases; Diagnosis; Germany; Germany, West; Humans; Legislation, Medical; Pyrimethamin | 1964 |